Novo Nordisk A/S
Healthy Returns: A key step forward for Novo Nordisk’s GLP-1 pill
Novo Nordisk flags flutter outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025. Tom Little | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. A closely watched pill from […]
Read More
Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s
Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to cut the cost of brand name GLP-1 weight loss drugs to $150 per month, a fraction of their current list price. “In London, you’d buy a certain drug for $130 and even less than that … $88 […]
Read More
Stocks making the biggest moves midday: Oracle, AST SpaceMobile, Revolution Medicines and more
Check out the companies making the biggest moves midday: AppFolio — The cloud-based business software provider climbed 7% after an upgrade to overweight from equal weight at KeyBanc, with a 12-month price target of $285, according to FactSet’s StreetAccount service. AST SpaceMobile — Shares in the space-based broadband cellular network dropped 6% after more than […]
Read More
Stocks making the biggest moves premarket: Jefferies, Oracle, Fifth Third, Micron and more
Check out the companies making headlines in premarket trading. Regional bank stocks — The subsector ticked higher after driving down the broader market on Thursday. Zions rose more than 1% on the back of a Baird upgrade , while Western Alliance bounced by less than 1%. The SPDR S & P Regional Banking ETF (KRE) […]
Read More
Stock futures are slightly lower after regional bank worries fuel market sell-off: Live updates
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 16, 2025. Jeenah Moon | Reuters U.S. stock futures were slightly lower on Thursday night after the previous session saw a sell-off fueled by concerns about regional banks’ loan practices. Futures tied to the Dow Jones Industrial […]
Read More
Stocks making the biggest moves after hours: Novo Nordisk, Interactive Brokers, CSX and more
Check out the companies making headlines in after-hours trading. CSX Corporation — Shares of the railroad jumped 2% on the back of its strong quarterly results. CSX reported adjusted earnings of 44 cents per share on revenue of $3.59 billion for its third quarter, just beating analysts’ earnings expectations of 42 cents per share on […]
Read More
Stocks making the biggest moves midday: Oracle, Ferrari, Delta, Albemarle and more
Check out the companies making the biggest moves in midday trading: Oracle — Shares of the software company rose more than 3% on Thursday after Baird initiated coverage with a outperform rating and a $365 price taget. The firm said Oracle has a strong position in the artificial intelligence growth story. The stock has had […]
Read More
Novo Nordisk shares slip after pharma giant announces $4.7 billion U.S. acquisition
LONDON — Shares of Danish pharmaceutical giant Novo Nordisk fell 1.1% on Thursday after the company announced plans to acquire U.S. biotech firm Akero Therapeutics. The deal will see Novo pay $54 per share, valuing Akero at $4.7 billion, with the acquisition also including a contingent value right of $6 per share, potentially adding another […]
Read More
Stocks making the biggest moves premarket: Ferrari, PepsiCo, Delta, Akero Therapeutics and more
Check out the companies making the biggest moves in premarket trading: Ferrari — The luxury carmaker tumbled nearly 14% after it trimmed its electrification targets . Ferrari said it expects its 2030 sports car model line-up to be made up of 40% internal combustion engine cars, 40% hybrid and 20% fully electric vehicles. That’s down […]
Read More
Novo Nordisk to buy Akero for up to $5.2 billion for promising liver drug
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little | Reuters Novo Nordisk said on Thursday it would buy Akero Therapeutics for up to $5.2 billion to add its promising experimental liver disease drug, in the first major deal […]
Read More